Introduction of transperitoneal lymphadenectomy in a gynecologic oncology center: analysis of 650 laparoscopic pelvic and/or paraaortic transperitoneal lymphadenectomies

Köhler, Christian; Klemm, P.; Schau, Anja; Possover, Marc; Krause, Norman; Tozzi, Roberto; Schneider, Achim

doi:10.1016/j.ygyno.2004.07.025

Cited by 183 publications

(125 citation statements)

References 46 publications

Supporting

Mentioning

102

Contrasting

Unclassified

Order By: Relevance

“…Although operating time in TPA surgery was not short, it gradually decreased with the experiences for this surgical approach. The median number of lymph nodes resected in our study was 36, and this number is sufficient compared to the results of other studies with a conventional laparoscopic or robotic approach (7)(8)(9). For pain analysis, we showed that TPA staging laparoscopy had tolerable postoperative pain.…”

Section: Discussionsupporting

confidence: 63%

Two-Port Access Staging Laparoscopy for Gynecologic Cancers

Paek¹,

Kim²

2011

Advanced Gynecologic Endoscopy

View full text Add to dashboard Cite

Section: Discussionsupporting

confidence: 63%

Two-Port Access Staging Laparoscopy for Gynecologic Cancers

Paek¹,

Kim²

2011

Advanced Gynecologic Endoscopy

View full text Add to dashboard Cite

“…Techniques and results of the first 650 procedures have already been published [19]. In 2004, 2 of the surgeons (A.S. and C.K.)…”

Section: Methodsmentioning

confidence: 99%

“…One hundred pelvic and para-aortic laparoscopic lymphadenectomies (LAEs) are proven to be necessary to standardize the procedure and minimize complications [18]. Moreover, it can take 3–4 years to harvest on average 10 para-aortic lymph nodes by laparoscopic LAE [19]. The pathologist’s contribution to lymph node count after pelvic and para-aortic LAE is barely investigated.…”

Section: Introductionmentioning

confidence: 99%

Implication of the Examining Pathologist to Meet the Oncologic Standard of Lymph Node Count after Laparoscopic Lymphadenectomy

Lanowska¹,

Vasiljeva²,

Chiantera³

et al. 2010

Oncology

Self Cite

View full text Add to dashboard Cite

Objective: The lymph node number as benchmark in oncologic operations depends on the patient’s anatomy, surgeon’s skill and pathologist’s accuracy. The influence of the pathologist is barely evaluated. Methods: A retrospective analysis of lymph node numbers after 700 laparoscopic lymphadenectomies in correlation to the examining pathologists was done. Three surgeons from the same department performed all operations at 2 campi, where 2 separate pathology institutions exist. Lymph node specimens were assigned randomly to any of the 62 involved pathologists. Results: The mean number of lymph nodes was equal for all surgeons. Lymph node specimens were analyzed in the pathology institute of campus I and II in 416 and 284 cases, respectively. The mean number of lymph nodes following pelvic and para-aortic lymphadenectomy was 36 at campus II and 30 at campus I (p < 0.0001). There was also a significant difference for pelvic (19.9 vs. 17.7; p < 0.0001) and para-aortic lymph node counts (16.2 vs. 14.1; p < 0.01) between both pathology institutes. At campus II, 22.6% of lymph node counts did not meet the oncologic standard for pelvic and 16.7% did not meet the standard for para-aortic lymph nodes. Moreover, at campus I, 35.5 and 20.8% of pathologists described less than the oncologic limit of pelvic and para-aortic lymph nodes, respectively. Conclusion: The number of removed lymph nodes is not an absolute parameter for surgical radicality. Interdisciplinary cooperation with pathologists is mandatory to meet oncologic standards.

show abstract

“…6 Para-aortic lymphadenectomy is essential for the accurate staging of cancer and aids in determining the appropriate treatment and possible therapeutic benefits in patients with gynecologic malignancies. 7,8 Our results regarding operative time (the mean operative time in group (1) was (176.5±6.4) while in group (2) patients who underwent ARH as control group. 9 In the TLRH group, the mean operating time increased statistically significantly (262.99 vs. 217.2 min).…”

Section: Resultsmentioning

confidence: 80%

Comparative study between open and laparoscopic lymphadenectomy (pelvic and para-aortic) in gynecological malignancies

Yassin¹,

ALShakhs

Hamed

et al. 2018

Int Surg J

View full text Add to dashboard Cite

Background: Objective of present study was to compare the results of lymphaenectomy (pelvic and para-aortic) between laparoscopy and laparotomy in gynecological malignancies.Methods: Authors analyze the results of 30 patients suffering from gynecological malignancies (Enometrial, Ovarian and cervical) submitted to surgery as apart of treatment. Patients were classified in Two Groups Group (1) included15 patients were submitted to open radical surgery and group (2) included 15 patients Were submitted to laparoscopic radical surgery between May 2016 and October 2017.Results: In present comparative study, there was significant difference regarding intra operative blood loss, operative time and post operative hospital stay (P<0.001) and there was no significant difference regarding intra-operative complications, post-operative complications, total number of lymph node harvested, number of positive lymphnodes (P>0.05).Conclusions: Laparoscopic lymphadenectomy is a technically feasible and safe procedure. Authors recommend further study in large number of patients with longer duration and follow up period for assessment of oncological out-come.

show abstract

Introduction of transperitoneal lymphadenectomy in a gynecologic oncology center: analysis of 650 laparoscopic pelvic and/or paraaortic transperitoneal lymphadenectomies

Cited by 183 publications

References 46 publications

Two-Port Access Staging Laparoscopy for Gynecologic Cancers

Two-Port Access Staging Laparoscopy for Gynecologic Cancers

Implication of the Examining Pathologist to Meet the Oncologic Standard of Lymph Node Count after Laparoscopic Lymphadenectomy

Comparative study between open and laparoscopic lymphadenectomy (pelvic and para-aortic) in gynecological malignancies

Contact Info

Product

Resources

About